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ABSTRACT
Purpose: To determine the prevalence of and risk factors for trachoma in selected local govern-
ment areas (LGAs) of Kwara State, Nigeria.
Methodology: Population-based cross-sectional surveys were conducted in eight LGAs of Kwara State
using Global Trachoma Mapping Project (GTMP) protocols. In each LGA, 25 villages were selected using
probability-proportional-to-size sampling; 25 households were selected from each village using com-
pact segment sampling. All residents of selected households aged ≥1 year were examined by GTMP-
certified graders for trachomatous inflammation—follicular (TF) and trichiasis using the simplified
trachoma grading scheme. Water, sanitation, and hygiene (WASH) data were also collected.
Results: A total of 28,506 residents were enumerated in 4769 households across the eight LGAs.
TF prevalence in children aged 1–9 years ranged from 0.2% (95% CI 0.0–0.3%) to 1.3% (95% CI
0.7–2.1%), while trichiasis prevalence in persons ≥15 years was <0.2% in each LGA. Access to
improved water source was the lowest in Edu (62%), while access to improved sanitation facilities
was the lowest in Asa (6%) and the highest in Ilorin East (64%). Children aged 1–4 years had 0.63
(95% CI 0.40–0.99) times lower odds of having TF compared to children aged 5–9 years. Children
in households with ≥5 resident 1–9-year-old children had 1.63 (95% CI 1.02–2.60) times greater
odds of having TF compared to those in households with <5 resident children.
Conclusion: Trachoma is not a public health problem in Kwara State. Provision of adequate water
and sanitation services should be a priority here, as a foundation for the health of the population.
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Introduction
Trachoma is the principal cause of blindness of infec-
tious origin worldwide.1 In Africa, where an estimated
171 million people are at risk,2 trachoma remains a
significant public health problem in many areas, but
until recently the district-level prevalence data neces-
sary to prompt commitment of resources for interven-
tions were vastly incomplete.3,4 The Global Trachoma
Mapping Project (GTMP)5 has now supported collec-
tion of those data for many more districts.
Infection of the conjunctival epithelium by particu-
lar strains6,7 of the bacterium Chlamydia trachomatis
stimulates a chronic inflammatory response, which may
be sufficient for a diagnosis of the sign trachomatous
inflammation—follicular (TF).8 The principal reservoir
of infection is in young children,9 and this age group is
therefore also most likely to have TF. Multiple infec-
tions with frequent or constant severe conjunctival
inflammation10–12 may lead to conjunctival scarring
and in-turning of the eyelashes. When misdirected eye-
lashes touch the eyeball, trachomatous trichiasis8 is
present. In some individuals, this results in irreversible
visual impairment. The prevalence of trichiasis
increases with age.13,14
There is no effective vaccine against C. trachomatis
infection.15 The World Health Organization (WHO)
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supports the use of the SAFE (surgery, antibiotics, facial
cleanliness, environmental improvement) strategy
against trachoma.16 To achieve elimination of trachoma
as a public health problem,17,18 community-based tri-
chiasis surgical services should be offered wherever the
prevalence of unmanaged trachomatous trichiasis in
≥15-year-olds is ≥0.2%, while the A, F, and E compo-
nents of SAFE should be implemented wherever the
prevalence of TF in 1–9-year-olds is ≥5%.
Nigeria is known to have a substantial burden of
trachoma.19–25 Kwara State, in the west of the country,
had a population of 2.4 million in 2006, the year for
which the most recent census data are available.26
Kwara State had not been previously surveyed for tra-
choma, and it was not known whether interventions
would be required here. The purposes of this study
were to estimate the district (local government area,
LGA)-level prevalence of TF in 1–9-year-olds and of
trichiasis in ≥15-year-olds, and to determine the pro-
portion of households with access to improved water
and sanitation facilities, in Kwara State. This informa-
tion was necessary to guide appropriate implementa-
tion of the SAFE strategy.27 Eight LGAs thought to
have the greatest trachoma risk (due to their location
to the north of the state24) were prioritized for survey
implementation; decisions on whether or not to pro-
ceed with surveys in other LGAs rested on trachoma
prevalence in this group of eight.
Methods
Trachoma graders and data recorders were trained and
certified according to the standard operating procedures
of the GTMP.28 Version 2 of the GTMP training system29
was used. Grader trainees were required to pass both a
slide-based test of diagnostic accuracy and a live subject-
based inter-grader assessment test, while recorder trai-
nees were required to pass an examination testing their
data capture accuracy, as described previously.28
In each LGA, a separate population-based preva-
lence survey was conducted according to the same
principles and using the same systems. Details of sam-
ple-size calculation have been reported elsewhere28;
briefly, each survey was powered to estimate an
expected TF prevalence in 1–9-year-olds of 10%, with
an absolute precision of 3% and a design effect of 2.65,
giving a desired minimum sample size of 1019.
Household selection
In each of the eight LGAs, 25 villages were selected using
a systematic, probability-proportional-to-population-size
methodology.27 In selected villages, 25 households were
selected using compact segment sampling.30,31
Data collection
All members of selected households aged ≥1 year were
eligible to be included. Graders used ×2.5 magnifying
loupes to examine both eyes of all consenting eligible
individuals for trichiasis, TF, and trachomatous inflam-
mation—intense (TI), defined according to the criteria
of the WHO simplified grading system.8 In accordance
with a WHO global strategy,32,33 collection of water,
sanitation, and hygiene (WASH) data was integrated
into the survey format, with household-level WASH
data generated through interviews with household
members and assessment of sanitation facilities. All
data were entered into the LINKS-GTMP app running
on Android smartphones, which also automatically col-
lected global positioning system coordinates for each
household.28 Data were uploaded to a secure cloud-
based server once the phones were within range of a
suitable network.28,34
Data analysis
Village-level proportions of children with TF were
adjusted for age in 1-year age bands using 2006 census
data.26 Village-level proportions of adults with trichia-
sis were adjusted for gender and age in 5-year age
bands using 2006 census data.26 LGA-level prevalence
was calculated as the means of the adjusted village-level
proportions. Confidence intervals (CIs) were deter-
mined by bootstrapping adjusted cluster-level propor-
tions, with replacement, over 10,000 replications.
We defined water sources and sanitation facilities as
“improved” using the criteria established by the WHO/
UNICEF Joint Monitoring Program (JMP) for Water
Supply and Sanitation, as reported up to 2015.35
Univariable and multivariable risk factor analyses
were conducted using R 3.3.3 (2017; R Foundation
for Statistical Computing, Vienna, Austria). We used
a multilevel hierarchical model to account for clus-
tering of TF in 1–9-year-olds at the village level.
Additional adjustment for clustering at the LGA
level did not significantly improve the model (like-
lihood ratio test (LRT), p = 0.1901). Prior to con-
ducting multivariable analyses, we used Mantel–
Haenszel tests of association to examine collinearity
between explanatory variables, but this was not an
absolute exclusion criterion. Univariable associations
found to be statistically significant were included in
the multivariable model (LRT, p < 0.10). Age and
gender were included in the multivariable model a
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priori, and a stepwise inclusion approach was used
to retain further variables in the final model if
found to be statistically significant (LRT, p < 0.05).
Ethical considerations
Ethical approval was provided by the National Health
Research Ethics Committee of Nigeria (NHREC/01/01/
2007) and the ethics committee of the London School
of Hygiene & Tropical Medicine (reference 6319).
Consent was obtained verbally and documented elec-
tronically. Consent for individuals aged <15 years was
given by a parent or guardian. Subjects noted to have
active trachoma were given a course of 1% topical
tetracycline eye ointment,36 and those with trichiasis
were referred to the nearest certified37 trichiasis
surgeon.
Results
A total of 28,506 residents were enumerated in 4769
households across the eight LGAs, which are shown
in Figure 1. In this population, 14,932 (52.4%) resi-
dents were female (Table 1). Graders examined
Figure 1. Local Government Areas (LGAs) surveyed, and prevalence of trachomatous inflammation—follicular (TF) in 1–9-year-olds,
by LGA, Global Trachoma Mapping Project, Kwara State, Nigeria, June and July, 2014.
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27,406 (96.1%) people in total; 859 (3.0%) people
were absent for the examination and 238 (0.8%)
people refused examination (Table 1). Of the exam-
ined individuals, 14,553 (53.1%) were female.
A total of 13,435 children aged 1–9 years were
examined, of whom 6641 (49%) were female. The age-
adjusted prevalence of TF in 1–9-year-olds ranged from
0.2% (95% CI 0.0–0.6%) in Edu to 1.3% (95% CI 0.7–
2.1%) in Kaiama (Table 1, Figure 1).
A total of 11,563 individuals aged ≥15 years were
examined. Of those, 6732 (58%) were female. The high-
est age- and gender-adjusted prevalence of trichiasis in
≥15-year-olds was 0.17% (95% CI 0.0–0.3%) in
Baruten. No individual examined in Edu or Kaiama
had trichiasis (Table 1).
In each LGA except Baruten, over 60% of house-
holds had access to an improved source of water for
face-washing within a 30-minute round trip.
Household access to improved sanitation ranged from
6% in Asa to 64% in Ilorin East (Table 2).
A histogram of TF prevalence by age in 1–9-year-
olds is shown as Figure 2. For the risk factor ana-
lysis with TF as the outcome variable, categorizing
age dichotomously (1–4 years v 5–9 years, LRT,
p = 0.047) was a better fit for the data than using
1-year age groups (LRT, p = 0.096). We therefore
categorized age as 1–4 years and 5–9 years. Results
of the univariable analysis are shown in Table 3.
The full results of the multivariable analysis are
shown in Table 4. Children aged 1–4 years had 0.63
(95% CI 0.40–0.99) times lower odds of having TF
compared to children aged 5–9 years. Children in
households with ≥5 children had 1.63 (95%
CI 1.02–2.60) times greater odds of having TF com-
pared to those in households with fewer than five
children.
Discussion
Trachoma is not a public health problem in any LGA of
Kwara State. The LGA-level TF prevalence in 1–9 year-
olds was <5%, and the trichiasis prevalence in ≥15-
year-olds was <0.2% in each LGA surveyed. That is
good news for Kwara and its people. Kogi State,
which borders Kwara to the east, also enjoys prevalence
of trachoma below those felt to represent a public
health problem,38 reinforcing the impression that
deployment of the SAFE strategy for trachoma elimina-
tion may be required in the northern half of
Nigeria,24,25,39–46 but not the southern half. Further
trachoma mapping in Kwara State is not presently
indicated.
Children aged 1–4 years examined as part of these
surveys were less likely to have TF than those aged
5–9 years. The older age group includes those commen-
cing primary school, where social interactions become
more frequent, and therefore risk of ocular C. tracho-
matis infection from nonfamily members might be
higher. However, this is pure speculation, and it is
hard to understand why such hypothesized infections
Table 1. Number of 1–9-year-old and number of ≥15-year-old resident, examined, absent, and refused; prevalence of trachomatous
inflammation—follicular (TF); and prevalence of trichiasis; by Local Government Area (LGA), Global Trachoma Mapping Project,
Kwara State, Nigeria, June and July, 2014.
1–9-year-olds ≥15-year-olds
LGA
Number of villages
sampled Resident Examined Absent Refused
TF prevalencea
(95% CI) Resident Examined Absent Refused
Trichiasis prevalenceb
(95% CI)
Asa 25 1546 1518 10 18 0.5 (0.1–0.9) 1489 1355 113 20 0.1 (0–0.2)
Baruten 25 1933 1892 16 24 0.9 (0.4–1.3) 1714 1593 88 33 0.2 (0–0.3)
Edu 25 1746 1732 2 12 0.2 (0–0.6) 1624 1428 173 23 0
Ifelodun 25 1513 1496 1 16 0.3 (0–0.7) 1432 1374 53 4 0.1 (0–0.2)
Ilorin
East
25 1656 1631 10 15 0.7 (0.2–1.2) 1456 1317 124 15 0.1 (0–0.2)
Kaiama 25 1745 1728 6 11 1.3 (0.7–2.1) 1645 1521 105 19 0
Moro 25 1570 1543 16 11 0.3 (0.1–0.6) 1609 1580 25 4 0.1 (0–0.2)
Pategi 25 1903 1895 5 3 0.9 (0.5–1.3) 1470 1395 72 3 0 (0–0.1)
Totals 200 13612 13435 66 110 N/A 12439 11563 753 121 N/A
aAdjusted for age in 1-year age bands (see text)
bAdjusted for gender and age in 5-year age bands (see text)
CI, confidence interval; N/A, not applicable.
Table 2. Household-level access to water and sanitation, by
Local Government Area (LGA), Global Trachoma Mapping
Project, Kwara State, Nigeria, June and July, 2014.
LGA
Households,
n
Improved
washing
water, n
(%)
Washing water source
(improved or
unimproved) <1km, n
(%)
Improved
sanitation,
n (%)
Asa 593 402 (68) 392 (66) 35 (6)
Baruten 613 392 (64) 365 (60) 86 (14)
Edu 615 379 (62) 522 (85) 204 (33)
Ifelodun 595 538 (90) 506 (85) 142 (24)
Ilorin
East
592 535 (90) 500 (84) 378 (64)
Kaiama 599 436 (73) 378 (63) 90 (15)
Moro 581 479 (82) 366 (63) 67 (12)
Pategi 581 450 (77) 416 (72) 102 (18)
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Figure 2. Prevalence of trachomatous inflammation—follicular (TF) by age among 1–9-year-olds, across eight surveyed Local
Government Areas, Global Trachoma Mapping Project, Kwara State, Nigeria, June and July, 2014.
Table 3. Univariable analysis of risk factors for trachomatous inflammation—follicular in 1–9-year-olds, Global Trachoma Mapping
Project, Kwara State, Nigeria, June and July, 2014.
Variable Number of cases, N Univariable ORa (95% CI)b p-valuec
Age, years 0.047
1–4 28 0.6 (0.4–1.0) -
5–9 61 - -
Sex 0.81
Male 46 1 -
Female 43 0.9 (0.6–1.4) -
Children aged 1–9 years in household, n 0.050
1–4 50 1 -
≥5 39 1.6 (1.0–2.6) -
Household sanitation facility 0.83
Improved 19 1 -
Unimproved 1 2.1 (0.2–18.1) -
Open defecation 69 1.0 (0.6–1.8) -
Household access to sanitation facility 0.96
Private 7 1 -
Shared or public 14 1.1 (0.4–3.0) -
No structure 68 1.0 (0.4–2.4) -
Household drinking water source 0.59
Improved 64 1 -
Unimproved 25 1.2 (0.7–2.0) -
Household water source for face-washing 0.33
Improved 63 1 -
Unimproved 26 1.3 (0.8–2.2) -
Time to main source of drinking water, minutes 0.60
<30 59 1 -
≥30 30 1.1 (0.7–1.9) -
Time to main source of water used for face-washing, minutes 0.95
<30 60 1 -
≥30 29 1.0 (0.6–1.7) -
Hand-washing facility within 15 m of sanitation facility 0.49
Yes 12 0.8 (0.4–1.6) -
No 77 1 -
Water available at the hand-washing facility 0.73
Yes 10 0.9 (0.4–1.8) -
No 79 1 -
Soap or ash available at the hand-washing facility 0.37
Yes 6 1.6 (0.6–4.0) -
No 83 1 -
Altitude, m above sea level 0.43
<250 42 1 -
≥250 47 1.2 (0.7–2.0) -
aUnivariable random effects regression accounting for clustering at village level.
bWald’s 95% confidence interval
cLikelihood ratio test
OR, odds ratio; CI, confidence interval
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from classmates would not have been passed on to
younger siblings. In any event, at TF prevalence as
low as those recorded here, it is difficult to be certain
that the follicular inflammation observed in the tarsal
conjunctivae of any of our examinees was necessarily
associated with C. trachomatis infection.47–50 We did
not carry out laboratory tests for C. trachomatis.51
Previous analyses of survey data from Nigeria found
no significant difference in the odds of TF in school-
going versus nonschool children.52
In addition to the above limitation, we note that
the work in Kwara State was implemented before
the GTMP began to routinely collect data on the
presence or absence of conjunctival scar in eyelids
noted to have trichiasis; we are therefore unable to
report whether the trichiasis we identified was likely
to be due to trachoma or to be trichiasis of other
etiologies.53 In any case, the prevalence of all-tri-
chiasis in adults was <0.2% in each LGA, so this
omission does not affect our conclusion that elim-
ination thresholds have been surpassed in this popu-
lation. GTMP approaches are recognized to be of
high epidemiological quality,54,55 and to provide an
advance over the more individualized survey
designs56 implemented prior to the inception of
the GTMP.
While most households had access to water sources
to facilitate hygiene practices like keeping faces clean,
access to sanitation was poor. Recent evidence has
highlighted the likely importance of full community
coverage and use of sanitation facilities for the elimina-
tion of trachoma.57,58 Until adequate sanitation services
reach all communities, many will remain at risk for
recrudescence of trachoma and for acquiring other
infections that flourish in unsanitary environments.
Greater efforts are needed here to accelerate progress
on universal access to safe and sustainable water and
sanitation.
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